- Home
- KALA vs MOBX Comparison
KALA vs MOBX Comparison
Compare KALA & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- MOBX
- Stock Information
- Founded
- KALA 2009
- MOBX 2020
- Country
- KALA United States
- MOBX United States
- Employees
- KALA N/A
- MOBX N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- MOBX
- Sector
- KALA Health Care
- MOBX
- Exchange
- KALA Nasdaq
- MOBX Nasdaq
- Market Cap
- KALA 26.2M
- MOBX 34.2M
- IPO Year
- KALA 2017
- MOBX N/A
- Fundamental
- Price
- KALA $5.10
- MOBX $0.75
- Analyst Decision
- KALA Strong Buy
- MOBX
- Analyst Count
- KALA 3
- MOBX 0
- Target Price
- KALA $14.00
- MOBX N/A
- AVG Volume (30 Days)
- KALA 71.3K
- MOBX 229.0K
- Earning Date
- KALA 08-05-2025
- MOBX 08-13-2025
- Dividend Yield
- KALA N/A
- MOBX N/A
- EPS Growth
- KALA N/A
- MOBX N/A
- EPS
- KALA N/A
- MOBX N/A
- Revenue
- KALA N/A
- MOBX $10,692,000.00
- Revenue This Year
- KALA N/A
- MOBX N/A
- Revenue Next Year
- KALA N/A
- MOBX N/A
- P/E Ratio
- KALA N/A
- MOBX N/A
- Revenue Growth
- KALA N/A
- MOBX 450.28
- 52 Week Low
- KALA $2.92
- MOBX $0.55
- 52 Week High
- KALA $11.20
- MOBX $2.47
- Technical
- Relative Strength Index (RSI)
- KALA 62.32
- MOBX 53.45
- Support Level
- KALA $4.36
- MOBX $0.72
- Resistance Level
- KALA $5.90
- MOBX $0.84
- Average True Range (ATR)
- KALA 0.50
- MOBX 0.09
- MACD
- KALA 0.07
- MOBX 0.01
- Stochastic Oscillator
- KALA 61.50
- MOBX 39.10
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.